HomeVNDA • NASDAQ
add
Vanda Pharmaceuticals Inc.
Previous close
$5.58
Day range
$5.47 - $5.69
Year range
$3.30 - $6.76
Market cap
318.93M USD
Avg Volume
2.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 47.46M | -24.06% |
Operating expense | 53.26M | -4.42% |
Net income | -4.15M | -227.49% |
Net profit margin | -8.74 | -268.08% |
Earnings per share | — | — |
EBITDA | -7.01M | -362.19% |
Effective tax rate | 11.11% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 394.14M | -21.41% |
Total assets | 652.68M | 1.26% |
Total liabilities | 108.69M | -0.10% |
Total equity | 544.00M | — |
Shares outstanding | 58.20M | — |
Price to book | 0.60 | — |
Return on assets | -3.55% | — |
Return on capital | -4.17% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -4.15M | -227.49% |
Cash from operations | 7.57M | -76.20% |
Cash from investing | -18.22M | -109.73% |
Cash from financing | — | — |
Net change in cash | -10.66M | -104.87% |
Free cash flow | 2.36M | -91.81% |
About
Founded
2002
Headquarters
Website
Employees
203